5 Gy irradiation does not alter the expression level of WT1 (Wilms tumor gene) in K562 and ML1

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2495-2497

  Yamazaki, Hideya ^a   Tang, Jin Tian ^a   Koizumi, Masahiko ^a   Kagawa, Kazufumi ^a   Inoue, Takehiro ^a   Imai, Atsushi ^a   Yoshida, Ken ^a   Shiomi, Hiroya ^a   Tanaka, Eiichi ^a   Nakamura, Hironobu ^a   Inoue, Toshihiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Northern blot; Radiation; Western blot; WT1

Indexed keywords

MESSENGER RNA;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN K 562; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IRRADIATION; LEUKEMIA CELL; LYMPHOBLAST; NEPHROBLASTOMA; PRIORITY JOURNAL;

DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, WILMS TUMOR; HUMANS; KINETICS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; WT1 PROTEINS;

EID: 14444276045     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Roase EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520, 1990.
2. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP: Homozygous deletion in Wilm's tumor of a zing-finger gene identified by chromosome jumping. Nature 343: 774-778, 1990.
3. Prithchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pellwtier J, Houseman DE, van Heyningen V, Hastie ND: The candidate Wilm's tumor gene is involved in genitourinary development. Nature 346: 194-197, 1990.
4. Buchler AJ: Isolation, characterization, and espression of the murine Wilm's tumor gene (WT1) during kidney development. Mol Cell Biol 11: 1707-1712, 1991.
5. Inoue K, Ogawa H, Yamagami T, Soma T, Tani Y, Tatekawa T, Oji Y, Tamaki H, Kyo T, Dohy H, Hiraoka A, Masaoka T, Kishimoto T Sugiyama H: Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood 88: 2267-2278, 1996.
6. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H; Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T: WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84: 3071-3079, 1994.
7. Tamaki H, Ogawa H, Inoue K, Soma T, Yamagami T, Miyake S, Oka Y, Oji Y, Tatekawa T, Tsuboi A, Tagawa S, Kitani T, Aozasa K, Kishimoto T, Sugiyama H, Miwa H, Kita K: Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia. Blood 88: 4396-4398, 1996.
8. Kudoh T, Ishidate T, Nakamura T, Toyoshima K, Akiyama T: Constitutive expression of the Wilms tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid. Oncogene 13: 1431-1439, 1996.
9. Kudoh T, Ishidate T, Moriyama M, Toyoshima K, Akiyama T: G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes. Proc Natl Acad Sei USA 92: 4517-4521, 1995.
10. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T, Kishimoto T: Growth inhibition of human leukemic cells by WT1 (wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood 87: 2878-2884, 1996.